Search Results 531-540 of 37923 for Two-phase

1. Hepatocellular carcinoma (HCC) - Survival rates - Mayo Clinic

   Stage C has a life expectancy of more than two years. Stage D has a life expectancy of 3 months. Request an appointment · StagesDoctors & departments.

2. Hypopharyngeal Cancer Clinical Trials

   Hypopharyngeal cancer. Displaying 7 studies. Phase ... (Stage I and Stage II). Additinoally, to evaluate ... There are two parts in this study. During the ...

3. Study of Magrolimab Combination Therapy to Treat Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... Phase 2 dose of magrolimab in combination with sacituzumab govitecan. In Cohort 2 (Safety Run-in Cohort 2 and Phase 2 Cohort 2) the study will evaluate the ...

4. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. A Study To Evaluate The Safety And Efficacy Of Two Dose Levels Of ONO-4578 With Opdivo®, In Combination With MFOLFOX6 And Bevacizumab Versus Standard Of Care In Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

6. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   This is a Phase II, multicenter, open-label, single arm, 2-stage study of tazemetostat 800 mg BID administered orally in continuous 28 day cycles. Screening of ...

7. Project 2: Improving the Endocrine Management of Premenopausal ER+/HER2- Breast Cancer - Mayo Clinic Research

   Breast tumors arising before menopause are more likely to be of an aggressive intrinsic subtype, of higher grade and at an advanced stage compared with ...

8. Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers - Mayo Clinic

   A Phase 1b/2, open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, ...

9. Head And Neck Cancers Clinical Trials - Mayo Clinic Research

   Part B: Phase 2 design which will randomize subjects 1:1 to either MEDI4736 alone or MEDI4736+ADXS11-001 in subjects who have failed at least 1 prior systemic ...

10. Chronic Lymphocytic Clinical Trials

    Phase 2 (stage 1): To evaluate the activity of single-agent Isatuximab at different doses/schedules and to select dose and regimen to further evaluate the ...